TipRanks
Advertisement
Advertisement
Psychedelic: Compass Pathways, GH Research report quarterly earnings
PremiumThe FlyPsychedelic: Compass Pathways, GH Research report quarterly earnings
3M ago
Enveric Biosciences reports new preclinical data on EB-003
Premium
The Fly
Enveric Biosciences reports new preclinical data on EB-003
3M ago
Enveric ‘welcomes’ final FDA guidance for psychedelic drug development
Premium
The Fly
Enveric ‘welcomes’ final FDA guidance for psychedelic drug development
3M ago
Enveric Biosciences Shareholders Approve Directors and Reverse Split
PremiumCompany AnnouncementsEnveric Biosciences Shareholders Approve Directors and Reverse Split
5M ago
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
Premium
The Fly
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
5M ago
Enveric Biosciences reports preclinical results from analysis of EB-003
Premium
The Fly
Enveric Biosciences reports preclinical results from analysis of EB-003
5M ago
Enveric issued U.S. patent for methods of treating psychiatric disorders
PremiumThe FlyEnveric issued U.S. patent for methods of treating psychiatric disorders
5M ago
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
Premium
The Fly
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
6M ago
Enveric Biosciences highlights preclinical data for EB-003
Premium
The Fly
Enveric Biosciences highlights preclinical data for EB-003
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―